1. Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments. (September 2022) Authors: Castenmiller, S.M.; de Groot, R.; Guislain, A.; Monkhorst, K.; Hartemink, K.J.; Veenhof, A.A.F.A.; Smit, E.F.; Haanen, J.B.A.G.; Wolkers, M.C. Journal: Immuno-oncology technology Issue: Volume 15(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗